Selective Degradation of Host MicroRNAs by an Intergenic HCMV Noncoding RNA Accelerates Virus Production  by Lee, Sanghyun et al.
Cell Host & Microbe
ArticleSelective Degradation of Host MicroRNAs
by an Intergenic HCMV Noncoding
RNA Accelerates Virus Production
Sanghyun Lee,1,2 Jaewon Song,1,2 Sungchul Kim,1,2 Jongkyu Kim,2,4 Yujin Hong,1,2 Youngkyun Kim,1,2 Donghyun Kim,1,2
Daehyun Baek,2,3,4 and Kwangseog Ahn1,2,*
1National Creative Research Initiatives Center for Antigen Presentation, Seoul 151-747, Republic of Korea
2Department of Biological Sciences
3Bioinformatics Institute
Seoul National University, Seoul 151-747, Republic of Korea
4Center for RNA Research, Institute for Basic Science, Seoul 151-747, Republic of Korea
*Correspondence: ksahn@snu.ac.kr
http://dx.doi.org/10.1016/j.chom.2013.05.007SUMMARY
Virulence of human cytomegalovirus (HCMV) clinical
isolates correlates with carriage of a 15 kb segment
in the UL/b0 region of the viral genome, which is
absent from attenuated strains. The mechanisms
by which this segment contributes to HCMV viru-
lence remain obscure. We observed that intergenic
RNA sequences within the 15 kb segment function
as a microRNA (miRNA) decay element (miRDE)
and direct the selective, sequence-specific turnover
of mature miR-17 and miR-20a encoded within the
host miR-17-92 cluster. Unlike canonical miRNA-
mRNA interactions, the miRNA-miRDE interactions
did not repress miRDE expression. miRNA binding
site mutations retargeted miRDE to other miR-17-
92 cluster miRNAs, which are otherwise resistant
to miRDE-mediated decay. miRDE function was
required to accelerate virus production in the context
of lytic HCMV infection. These results indicate a role
for viral noncoding RNA in regulating cellular miRNAs
during HCMV pathogenesis and suggest that non-
coding RNAs may play a role in mature miRNA
turnover.
INTRODUCTION
Human cytomegalovirus (HCMV) is a member of the b-herpes-
virus subfamily and a ubiquitous human pathogen. After primary
infection, HCMV establishes a lifelong latent infection in periph-
eral blood cells (So¨derberg-Naucle´r et al., 2001). HCMV infec-
tions in healthy individuals are typically asymptomatic and
remain the leading cause of birth defects and the major cause
of infectious mortality and morbidity in immune-compromised
patients (Britt, 2008). Historically, HCMV research has primarily
relied on attenuated strains (AD169 and Towne) extensively
passaged in fibroblasts (Goodrum et al., 2007). Attenuated
HCMV strains have acquired genome rearrangements that678 Cell Host & Microbe 13, 678–690, June 12, 2013 ª2013 Elsevierdistinguish them from HCMV clinical strains. For example, the
genome of the HCMV clinical strain Toledo contains an addi-
tional 15 kb segment in the UL/b0 region, which is present in all
virulent strains but not in the attenuated strain AD169 (Murphy
et al., 2003). HCMV clinical strains and attenuated strains have
striking differences in virulence and cell tropism. The 15 kb
segment plays a critical role in clinical pathogenesis in vivo
and contains at least 19 open reading frames (ORFs) and 1 viral
microRNA (miRNA). The functions of the viral genes encoded in
the 15 kb segment are associated with cell tropism (Hahn et al.,
2004; Revello and Gerna, 2010), latency (Goodrum et al., 2007),
cytokine regulation (Kim et al., 2012; Penfold et al., 1999), and
NK cell responses (Wills et al., 2005). However, the mechanisms
underlying the high virulence of the clinical strains remain poorly
understood.
miRNA is an approximately 22 nucleotide (nt) noncoding RNA
that regulates gene expression at the posttranscriptional level.
The human genome is predicted to encode >1,000 miRNAs
that regulate more than one-third of all human transcripts (Chang
and Mendell, 2007). miRNAs are transcribed as long primary
transcripts (pri-miRNAs) by RNA polymerase II (Lee et al.,
2004) and cropped into hairpin-shaped RNA precursors (pre-
miRNAs) by the nuclear RNase III Drosha (Lee et al., 2003).
RNase III Dicer further processes pre-miRNAs in the cytoplasm
into approximately 22 nt miRNA duplexes (Bernstein et al.,
2001; Hutva´gner et al., 2001; Ketting et al., 2001; Knight and
Bass, 2001), one strand of which is typically incorporated into
Argonaute proteins (Khvorova et al., 2003; Schwarz et al.,
2003). miRNA expression is primarily regulated at the transcrip-
tional level, and in some casesmiRNA biogenesis might be regu-
lated at the posttranscriptional level (Krol et al., 2010). The
steady-state levels of miRNA are a function of biogenesis and
turnover. In contrast to miRNA biogenesis, much less is known
about the turnover of miRNAs.
A prominent characteristic of miRNAs is that their genes are
often closely clustered within the genome. More than 30% of
humanmiRNAs are predicted to be encoded within polycistronic
miRNA clusters (Altuvia et al., 2005). These clustered miRNAs
are transcribed and processed from polycistronic primary
transcripts. Most studies on clustered miRNAs have demon-
strated their functional redundancy and coordinated regulationInc.
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miR-17-92 encodes six miRNAs (miR-17, miR-18a, miR-19a,
miR-20a, miR-19b-1, and miR-92a-1) that function as onco-
genes (He et al., 2005). The expression of these miRNAs regu-
lates the same cellular process to achieve homeostasis either
individually or in a coordinated manner (Olive et al., 2010). The
functional dissection of each miRNA has been performed using
an in vivo tumorigenic model (Mavrakis et al., 2010; Mu et al.,
2009; Olive et al., 2009; Shan et al., 2009). The key oncogenic
component of themiR-17-92 cluster miR-19 induces lymphoma-
genesis by targeting the apoptotic genes Pten and Bim (Mavra-
kis et al., 2010; Mu et al., 2009; Olive et al., 2009). Furthermore,
the overexpression of miR-17 results in reduced cell adhesion,
migration, and proliferation (Shan et al., 2009). However, whether
individual miRNAs in a cluster undergo differential regulation at
the posttranscriptional level and have distinct functions is not
yet known.
To elucidate the pathogenesis of HCMV clinical strains, we
investigated virus-host miRNA interactions and identified a viral
intergenic noncoding RNA element, composed of highly con-
served sequences throughout HCMV clinical strains, which
selectively degrades the miR-17 family members of the miR-
17-92 cluster and accelerates virus production. These results
show that the interplay between the viral noncoding RNA and
cellular miRNAs might be important for elucidating HCMV path-
ogenesis. These results also provide further insight into the role
of the human noncoding RNA genome in the regulation of cellular
miRNA turnover.
RESULTS
The HCMV Clinical Strain Differentially Regulates the
Expression of the miR-17-92 Cluster
miRNA microarrays were used to investigate host miRNA
expression profiles during HCMV clinical strain infection. Human
foreskin fibroblasts (HFFs) were infected with the HCMV clinical
strain Toledo. To mimic the attenuated strain, we used
ToledoD15kb, which lacks the 15 kb genomic segment in the
UL/b0 region (Wang et al., 2005). The miRNA expression profile
showed that several host miRNAs were regulated during
HCMV infection (Figure 1A). miR-100, miR-199a-3p, miR-199a-
5p, and miR-199b-5p were downregulated during infection
with Toledo-wild-type (WT) and ToledoD15kb, consistent with
previously reported data (Santhakumar et al., 2010; Wang
et al., 2008). Notably, we identified host miRNAs that were
regulated during HCMV infection. miR-29a/b/c, miR-125b,
miR-199a-3p, and miR-199a-5p were downregulated at the pri-
mary miRNA level (see Figure S1 online).
Interestingly, we observed that Toledo-WT differentially regu-
lated the levels of mature miRNAs within the miR-17-92 cluster.
The miR-17-92 cluster contains six miRNAs: miR-17, miR-18a,
miR-19a, miR-20a, miR-19b, and miR-92a. These miRNAs are
categorized into four miRNA families according to their seed
sequences: miR-17 (miR-17 and miR-20a), miR-18 (miR-18a),
miR-19 (miR-19a and miR-19b), and miR-92 (miR-92a) (Fig-
ure 1B). Northern blotting and qRT-PCR analyses confirmed
that Toledo-WT downregulated two homologous mature
miRNAs, miR-17 and miR-20a, but upregulated miR-18a, miR-
19a, miR-19b, and miR-92a (Figures 1C and 1D). The differentialCell Hregulation of the miR-17-92 cluster occurred in Toledo-WT
but not in ToledoD15kb-infected cells. ToledoD15kb infection
increased the expression of themiR-17 andmiR-20a (Figure 1E).
The attenuated HCMV strain AD169 exhibited results similar to
those of ToledoD15kb. AD169 induced all six miRNAs in the
miR-17-92 cluster during infection (Figure S1). These results
demonstrate that the HCMV clinical strain Toledo differentially
regulates the expression of miRNAs within themiR-17-92 cluster
at the posttranscription level, indicating that the 15 kb region is
responsible for the observed phenotype.
HCMV Infection Induced Primary Transcription of the
miR-17-92 Cluster, Followed by the Selective
Downregulation of Mature miR-17 and miR-20a
The differential expression of individual miRNAs within the same
miRNA cluster was surprising and unexpected. To further inves-
tigate the differential regulation of the miR-17-92 cluster, we
examined whether Toledo affects the transcription of primary
miR-17-92 (pri-miR-17-92). During Toledo infection, pri-miR-
17-92 levels gradually increased at 72 hr postinfection (hpi) (Fig-
ure 2A), which has also been observed during ToledoD15kb
infection (Figure 2B). Previous studies have reported that E2F
family activates the transcription of the miR-17-92 cluster
(Sylvestre et al., 2007), HCMV immediate early protein 1 (IE1) in-
teracts with E2F1 during infection (Margolis et al., 1995), and
HCMV immediate early protein 2 (IE2) increases the expression
of E2F-response genes (Hagemeier et al., 1994; Song and Stin-
ski, 2002); therefore, we hypothesized that HCMV IE1 and IE2
could be responsible for the observed upregulation of pri-miR-
17-92 expression during Toledo infection. Indeed, the ectopic
expression of either IE1 or IE2 increased the pri-miR-17-92
levels, and the coexpression of these proteins increased the in-
duction of pri-miR-17-92 expression (Figure 2C). To examine
whether IE1 and IE2 elevate pri-miR-17-92 expression during
infection, we generated siRNAs specific for IE1 and IE2. The
siRNA-mediated knockdown of IE1 and/or IE2 inhibited the
upregulation of pri-miR-17-92 (Figure 2D). These results indicate
that HCMV IE1 and IE2 play a role in inducing primary miR-17-92
transcription.
Next, we investigated the mechanisms by which Toledo
downregulates the levels of the mature forms of miR-17 and
miR-20a. Northern blot analysis indicated that the precursor
miRNAs (pre-miRNAs) of miR-17 and miR-20a are gradually
increased during infection. In contrast to the results for pre-
miRNA, the mature levels of miR-17 and miR-20a were dramat-
ically reduced during infection (Figure 2E). We quantified the
miR-17* and miR-20a* levels using qRT-PCR analysis, revealing
that the expression of these miRNAs was increased (Figure S2).
These results demonstrate that Toledo initially induces the tran-
scription of pri-miR-17-92 and selectively downregulates the
miR-17 family (miR-17 and miR-20a) of the miR-17-92 cluster
at the mature level.
HCMV Clinical Strain-Specific RNA Mediates the
Turnover of themiR-17 andmiR-20a through Sequence-
Specific RNA-miRNA Interactions
To identify the viral factors involved in the selective degradation
of miRNAs within the miR-17 family, we treated cells with
either the transcriptional inhibitor actinomycin D (ActD) or theost & Microbe 13, 678–690, June 12, 2013 ª2013 Elsevier Inc. 679
Figure 1. Differential Regulation of miR-17-92 Cluster Expression by the HCMV Clinical Strain
(A) Changes in miRNA expression upon HCMV infection. Human foreskin fibroblasts (HFFs) were infected with Toledo-WT or ToledoD15kb for miRNAmicroarray
(5moi). ThemiRNA expression levels of virus-infected HFFs at 24 or 72 hpi were comparedwith those for the noninfected control. The color scale is based on log2
changes in expression.
(B) Organization of the miR-17-92 cluster. This cluster can be grouped into four families: miR-17 (miR-17 and miR-20a), miR-18 (miR-18a), miR-19 (miR-19a, b),
and miR-92 (miR-92a). The seed sequences of miRNAs are indicated in red.
(C and D) Northern blot (C) and quantitative RT-PCR (qRT-PCR) (D) analyses of the mature miRNA levels in the miR-17-92 cluster during HCMV Toledo infection
(5 moi).
(E) Northern blot analysis ofmiR-17,miR-20a, andmiR-19a in HFFs infectedwith Toledo-WT or ToledoD15kb (5moi). NI indicates the noninfected control, and the
error bars represent ± 1 SD. See also Figure S1.
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Figure 2. Temporal Regulation of miR-
17-92 Cluster Expression during HCMV
Infection
(A and B) qRT-PCR results for the primary miR-17-
92. HFFs were infected with either Toledo-WT or
ToledoD15kb (5 moi).
(C) Using the adenoviral expression system,
HCMV IE1 and IE2 were expressed in HFFs.
Adenovirus containing the trans-activator gene
(Ad-Trans) was used for the control infection.
HFFs were infected with either adenovirus-IE1
(Ad-IE1) or adenovirus-IE2 (Ad-IE2) at 10 moi.
After 48 hr, the pri-miRNA was analyzed using
qRT-PCR.
(D) The loss-of-function study of HCMV IE1 and
IE2 for the induction of miR-17-92. HFFs were
transfected with IE1 or IE2-specific siRNAs (final
concentration, 20 nM) and subsequently infected
with Toledo-WT (2 moi). At 3 dpi, the infected cells
were harvested to quantify the pri-miRNA tran-
scripts. The anti-IE1 and anti-IE2 blots show the
efficiency of IE1 and IE2 knockdown (right panel).
(E) Northern blot analysis demonstrating the
expression of the precursor and mature form of
miR-17 and miR-20a during Toledo infection. U6
snRNA was used as a loading control. NI indicates
the noninfected control, and the error bars
represent ± 1 SD. See also Figure S2.
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treatments suppressed the upregulation of miR-19a by Toledo
(Figure 3A, left), suggesting that the Toledo-mediated upregula-
tion of miR-19a requires the synthesis of both RNA and protein.
Interestingly, ActD, but not CHX, blocked the Toledo-induced
reduction of miR-17 expression, suggesting that viral RNA is
involved in mediating the downregulation of miR-17 (Figure 3A,
right).
To identify the location of the regulatory elements within the
15kb-UL/b0 region, we generated partial genomic clones of
the 15 kb region to determine which clones could induce the
degradation of miR-17 (Figure 3B). Clone 3 induced the downre-
gulation of mature miR-17 when transfected into ToledoD15kb-
infected HFFs (Figure 3C, left), without affecting pri-miR-17-92
levels (Figure 3C, right). A major polycistronic transcript of
approximately 1.6 kb in length has been identified within the 3Cell Host & Microbe 13, 678–6kb region of clone 3 (He et al., 2011;
Stern-Ginossar et al., 2012). This tran-
script (hereafter called UL144-145 RNA)
contains the 50UTR, the UL144 ORF, an
intergenic region, the UL145 ORF, and
30UTR sequences (Figure 3D) and ex-
hibits ‘‘early’’ viral gene expression
kinetics (Figure S3). In Figure 3A, we
observed that the degradation pheno-
type of miR-17 was abolished in ActD-
treated cells but not in CHX-treated cells.
UL144-145 RNA was normally expressed
in DMSO- or CHX-treated cells, but
reduced UL144-145 RNA was observed
in ActD-treated cells (Figure S3). We
also confirmed that UL144-145 RNAwas expressed in Clone 3-transfected HFFs, and the expression
level was comparable with that in Toledo-WT-infected cells
(Figure S3).
To determine the potential association between the viral RNA
element and miRNA turnover (Figure 3A), we examined whether
the UL144-145 RNA element alone is sufficient to mediate
miRNA turnover. Using the bioinformatics algorithmRNAHybrid,
we identified a favorable miRNA-binding site within the inter-
genic region of UL144-145 RNA (Figure 3D). An analysis of the
secondary structure of the intergenic region of UL144-145 RNA
using RNAfold software (Gruber et al., 2008) showed that the
miR-17 binding site of UL144-145 RNA comprises a bulged
bipartite non-base-paired nucleotide sequence complementary
tomiR-17, separated by six intramolecular base pairs (Figure 3E).
The 3-dimensional structure model, constructed using the
Rosetta program (Das and Baker, 2007), predicted that the90, June 12, 2013 ª2013 Elsevier Inc. 681
Figure 3. The Intergenic Noncoding Region in UL144-145 RNA Mediates the Downregulation of Mature miR-17 and miR-20a through
Sequence-Specific Interactions
(A) Drug-sensitivity assay. At 12 hpi Toledo-WT (5 moi), HFFs were treated with DMSO as a control, actinomycin D (ActD), or cycloheximide (CHX). After 36 hr, the
total RNA from the HFFs was used for quantitative analysis.
(B) Illustration of the recovery test. The partial genomic sequences of the 15 kb region were cloned into a promoterless vector (pBlueScript). HFFs were infected
with ToledoD15kb (5 moi) and transfected with the partial genomic clones.
(C) Mature miR-17 and pri-miR-17-92 transcript levels quantified using qRT-PCR.
(D) Schematic of the UL144-145 RNA locus in clone 3. The miR-17-binding site was mapped to the intergenic region between UL144 and UL145.
(E) Two-dimensional representation for the intergenic region of UL144-145 RNA using RNAfold software. Both the 50 and 30 complementary sequences to miR-17
(red) and the central bulge of the miR-17 binding site (blue) are indicated.
(legend continued on next page)
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ing site together, creating a favorable structure for miR-17 bind-
ing (Figure S3). The overexpression of UL144-145 RNA in
HEK293T cells resulted in the specific downregulation of miR-
17 and miR-20a in a dose-dependent manner, and the miR-
19a levels remained unchanged (Figure 3F).
These results suggested that the UL144-145 RNA mediates
the decay of miR-17 and miR-20a. The mutated UL144-145
RNA, containing a triple-nucleotide substitution mutation in the
miR-17 seed binding site, could no longer downregulate miR-
17 and miR-20a (Figure 3G), demonstrating that UL144-145
RNA functions through sequence-specific interactions with
miRNA. To further characterize the importance of sequence-
specific interactions in the UL144-145 RNA-mediated degrada-
tion of miRNA, we determined whether UL144-145 RNA could
be retargeted to other miRNA family members from the miR-
17-92 cluster that were not subjected to Toledo-induced degra-
dation. The UL144-145 RNA-binding site for miR-17 was
replaced with the binding site for miR-18a. This mutant could
effectively downregulate miR-18a, whereas it could no longer
target miR-17 and miR-20a for degradation (Figure 3H). Simi-
larly, point mutations in the UL144-145 RNA complementary
to the seed sequence of miR-92a resulted in the specific degra-
dation of miR-92a (Figure S3). Taken together, these data
demonstrate that the UL144-145 RNA-mediated degradation
of miRNAs occurs in a sequence-specific manner.
Identification of a miRDE that Directs the Turnover of
miRNA through Noncanonical miRNA-mRNA
Interactions
To identify the core element required for the degradation of miR-
17 family members and understand the nature of miRNA-target
RNA interactions, we generated a series of firefly luciferase
reporter constructs based on the 240 nt intergenic region
harboring the miR-17 binding site (Figure 4A). Both the firefly-
736nt and firefly-240nt constructs could downregulate the
expression of miR-17 and miR-20a (Figure 4B), indicating that
the 240 nt intergenic region of UL144-145 RNA is sufficient for
the downregulation of the miR-17 family (sequence information
in Figure S4). Notably, based on the luciferase activity of
firefly-240nt observed in cells overexpressing miR-17 or miR-
20a (Figure 4C), we did not observe miR-17- or miR-20a-
mediated targeting of firefly-240nt RNA, which is required for
canonical miRNA-mRNA interactions.
These results demonstrated that opposite outcomes inmiRNA
or mRNA degradation depend on the nature of the miRNA-
mRNA interactions. Firefly-30nt did not downregulate the miR-
17 transcript level, indicating that the miR-17-binding sequence
alone is not sufficient for inducing miR-17 turnover (Figure 4D).
To identify the minimal sequence for miR-17 degradation, we
analyzed a series of deletion mutants and observed that the(F) qRT-PCRdetection ofmaturemiRNA transcripts resulting from a dose-depend
vector.
(G) miRNA transcript levels of UL144-145 RNA with mutations in the miR-17 see
(H) Introduction of mutated binding sites into UL144-145. The miR-17 binding s
17/18a).
(G and H) miRNA transcript levels of HEK293T cells transfected with the indicate
t test). NS represents nonspecific, and the error bars represent ± 1 SD. See also
Cell Hadditional 20 nt (D3-2 to D3-6 region) adjacent to the 30 nt miR-
17 binding site was essential for miR-17 downregulation (Fig-
ures 4F and 4G). Thus, this approximately 50 nt viral intergenic
noncoding RNA region sequence represents the ‘‘miRNA decay
element’’ (miRDE; miRDE sequence information in Figure S4).
To further validate the ability of miRDE to degrade miRNA and
evaluate the use of miRDE as a tool for studying miRNA regula-
tion, we generated a 50-mer RNA oligo (miRDE-50-mer_WT) to
determine whether miRDE could serve as a short RNA oligomer.
The expression of miR-17 was reduced in a dose-dependent
manner in miRDE-transfected cells (Figure 4H), but not in cells
transfected with the miRDE seed mutant (miRDE-50-mer_seed
mut) containing a mutated miR-17 binding site (Figure 4I). The
30-mer RNA oligo (miRDE-30-mer), containing solely the miR-
17 binding site, resulted in relatively inefficient downregulation
(Figure 4J). These results indicate that the 50-mer viral intergenic
noncoding RNA region sequence is essential and sufficient for
regulating the miR-17 family and functions independently of
mRNA context.
miR-17 Binding-Site Mutant HCMV Loses the Ability to
Differentially Regulate the miR-17-92 Cluster
We observed that the viral intergenic RNA sequence mediates
the selective turnover of miR-17 and miR-20a, using an expres-
sion vector or RNA oligomer. To further investigatemiRDE-medi-
ated miRNA regulation during viral infection, we generated a
Toledo mutant virus with a triple-nucleotide substitution muta-
tion in the miRDE seed-binding site for miR-17 (ToledoD17Seed)
and its revertant virus (Toledo-Rev) (Figure 5A). The expression
of mature miR-17 and miR-20a was reduced in Toledo-WT and
Toledo-Rev-infected cells, whereas the expression of these
miRNAs was significantly increased in ToledoD17Seed-infected
cells (Figure 5B). The levels of the precursor miR-17 andmiR-20a
transcript increased in all three viruses during infection (Fig-
ure 5B), and the pri-miR-17-92 and UL144-145 transcript levels
were similar between these viruses (Figures 5C and 5D). Next,
using a pulse-chase experiment with synthetic miR-17 duplexes,
we examined whether the miRDE of Toledo could destabilize the
mature miR-17. Prior to the experiment, we verified that the
amount of exogenous miR-17 is much higher than the amount
of endogenous miR-17 (Figure S5). After HFFs were infected
with mock, Toledo-WT, or ToledoD17Seed and transfected
with the miR-17/miR-17* duplex, we monitored the levels of
miR-17 as a function of time. The Toledo-WT-infected cells ex-
hibited higher rates of exogenous miR-17 degradation than did
themock or ToledoD17Seed-infected cells (Figure 5E). These re-
sults indicate that miRDE facilitates the degradation of mature
miR-17 in the context of viral infections. We also investigated
whether the degradation ofmiR-17 family is dependent on a spe-
cific Argonaute protein. We designed specific siRNAs targeting
members of the Argonaute family (siAgo1, siAgo2, siAgo3, andent transfection of HEK293T cells with UL144-145RNA cloned into a pcDNA3.1
d-binding site (UL144-145 seed mut).
ite of UL144-145 RNA was changed to an miR-18a binding site (UL144-145
d constructs, as detected using qRT-PCR (**p < 0.01; *p < 0.05 by Student’s
Figure S3.
ost & Microbe 13, 678–690, June 12, 2013 ª2013 Elsevier Inc. 683
Figure 4. Identification of the Minimal Sequence Requirement for miR-17 Decay
(A) Schematic of the construction of the following firefly luciferase reporter systems: firefly-736nt containing the intergenic region, UL145 ORF, and 30UTR; firefly-
240nt, containing only the intergenic region; and firefly-30nt, containing only the miR-17 binding site.
(B) Overexpression of the reporter constructs in HEK293T. Fold change in miR-17 and miR-20a, but not pri-miR-17-92, expression through Firefly-736nt and
Firefly-240nt, detected using qRT-PCR.
(C) miRNA targeting assay. HEK293T cells were cotransfected with Renilla luciferase, the firefly-240nt vector, and the indicated amount of miR-17 or miR-20a
using liposomes. Twenty-four hours posttransfection, the luciferase activity of transfected cells was determined. The relative luciferase activity was calculated as
the ratio of firefly to Renilla luciferase activity.
(D) Effects of firefly-30nt on miR-17 decay.
(E) Schematic of the deletion screening of the UL144-145 intergenic region to identify the additional motif.
(F) Primary screening with 40 nt scale deletion.
(G) Secondary screening with 4 nt scale deletion in D3 region.
(H–J) Synthetic RNA oligomers of the minimized viral intergenic RNA. The nucleotide sequences of miRDE RNA oligomers are shown in Figure S3. HEK293T cells
were transfected with the indicated amount of RNA oligomers, and the total RNA was analyzed using qRT-PCR. (H) 50 nt RNA oligomer containing an miR-17-
binding site and an additional 30 additional motif in miRDE (miRDE-50-mer_WT). (I) miRDE wild-type oligomer (miRDE-50-mer_WT) or the miR-17 seed binding-
site mutant oligomer (miRDE-50-mer_seed mut). (J) RNA oligomer containing the sole miR-17 binding site of miRDE (miRDE-30-mer). (H–J) The mature miRNA
levels were quantified using qRT-PCR. The error bars represent ± 1 SD. See also Figure S4.
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Figure 5. A Mutant Virus with Triple Base Substitution in the miR-17 Binding Site Is No Longer Able to Target the Mature miR-17 for
Degradation
(A) Schematic of the miR-17 binding site mutant virus (ToledoD17Seed). Mutated residues in the miR-17-binding site are shown (CAC/ACA, red).
(B–D) HFFs were infected with Toledo-WT, ToledoD17Seed, or Toledo-Rev (2 moi). The infected cells were harvested at the indicated times, and the total RNA
was analyzed. (B) Northern blots showing the expression levels of the pre-miR-17 (top panel), the mature miR-17 (second panel), the pre-miR-20a (third panel),
and the mature miR-20a (fourth panel). (C) Pri-miR-17-92 levels quantified using qRT-PCR. (D) Levels of UL144-145 transcripts detected using qRT-PCR.
(E) Stability of maturemiRNA during HCMV infection, determined using pulse-chase assays. qRT-PCRwas used tomeasure the abundance ofmiR-17 transcripts
at the indicated time points after transfection with synthetic miR/miR* duplex, and 0.2 nM of the miR-17/miR-17* duplex was transfected. The error bars
represent ± 1 SD. See also Figure S5.
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treatedwith the specific siRNAs for 2 days, and themiR-17 levels
were assessed at 48 hpi. The degradation of miR-17 during
infection was not affected by the specific knockdown of Ago
genes (Figure S5), suggesting that the decay of miR-17 during
infection is not dependent on a specific Ago protein.
miRDE-Mediated Regulation of the miR-17 Family
Accelerates Virus Production
To determine the physiological relevance of these observations,
we assessed the effects of the miRDE-mediated regulation
of miR-17 on viral lytic growth after infecting HFFs with
Toledo-WT or ToledoD17Seed at an moi of 2. Interestingly, at
early viral infection, ToledoD17Seed-infected HFFs showed
less viral production than Toledo-WT-infected HFFs. Virus
production was 80-, 40-, and 4-fold reduced at 2, 3, and 4 dpi
in ToledoD17Seed-infected cells compared with that in
Toledo-WT-infected cells. The viral production in Toledo-WT
and ToledoD17Seed-infected cells reached a plateau at 5 dpi,
presumably due to adverse environmental conditions (Figure 6A).
The synthesis of the viral genome in ToledoD17Seed-infected
cells was delayed and reduced (Figure 6B). ToledoD17Seed-Cell Hinfected cells showed partially reduced viral gene expression
at 2 dpi, but the viral gene expression at 3–4 dpi was largely
similar to that of Toledo-WT-infected HFFs (Figure 6C). Because
miR-17 targets apoptotic genes, we used an Annexin V assay to
measure apoptosis during Toledo-WT or ToledoD17Seed infec-
tion in HFFs. The rate of apoptosis was low and similar in Toledo-
WT- and ToledoD17Seed-infected cells (Figure S6).
We designed a rescue experiment using an antisense oligomer
against miR-17 and miR-20a during infection. The specific anti-
sense inhibitor against miR-17 and miR-20a significantly
rescued the viral growth of ToledoD17Seed to a degree compa-
rable with the growth of Toledo-WT (Figure 6D). Consistent with
these results, ToledoD15kb produces infectious viruses at 1 day
later than the parental viruses, with delayed growth rates (Wang
et al., 2005), suggesting that miR-17 dysregulation could cause
the growth delay of ToledoD15kb. Taken together, these data
show that the degradation of miR-17 family accelerates viral pro-
duction during HCMV infection. The functional importance of
miRDE-mediated regulation of the miR-17 family within the
miR-17-92 cluster might be supported throughmiRDE sequence
conservation in all HCMV clinical isolates (Figure 6E). An analysis
of the 4.2 kb genomic region encoding UL142 to UL147 from 14ost & Microbe 13, 678–690, June 12, 2013 ª2013 Elsevier Inc. 685
Figure 6. Degradation of miR-17 by miRDE Is Essential for the Rapid Viral Production during Lytic Infection
(A–C) HFFs were infected with Toledo-WT and ToledoD17Seed at 2 moi. (A) Growth curves of Toledo-WT and ToledoD17Seed. The titer of cell-free virus in the
supernatants of infected cultures was determined using limiting dilution analyses. The error bars represent ± 1 SD. (B) The levels of viral genomic DNA in HCMV-
infected cells were determined using qPCR. The error bars represent ± 1 SD. (C) Immunoblot analysis for the detection of HCMV immediate early proteins (IE1 and
IE2) and late (gB) genes.
(legend continued on next page)
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harboring miRDE shows a remarkably high degree of sequence
conservation. Particularly, the miR-17-binding sites are com-
pletely conserved in all HCMV clinical strains, suggesting the
evolutionary adaptation of viruses to counteract cellular miRNA
regulation.
DISCUSSION
An intriguing aspect of this study is that the HCMV clinical strain
regulates the hostmiR-17-92 cluster differentially and temporally
by manipulating multiple steps of miRNA biogenesis during
infection. We demonstrated that a 50 nt miRNA decay element
(miRDE), comprising viral intergenic noncoding RNA region
sequences, was specific for clinical strains and conserved in
all HCMV clinical isolates. This miRDE was sufficient to induce
the selective degradation of the miRNAs of the miR-17 family
and other miRNAs via target site replacement. When the degra-
dation of miR-17 throughmiRDEwas abrogated, delayed HCMV
production during lytic infection was observed, supporting the
physiological relevance of miRDE-mediated miR-17 decay.
HCMV is predicted to contain over 250 ORFs (Murphy et al.,
2003; Stern-Ginossar et al., 2012). Most viruses have evolved
diverse strategies to maximize the coding capacity in a compact
genome size. For example, many HCMV genes are transcribed
as a polycistron. The ORFs in a polycistron use a common pro-
moter element or polyadenylation signal (Ma et al., 2012). HCMV
cDNA library screening showed that 45%of the RNA transcribed
from the HCMV genome was noncoding (Zhang et al., 2007).
Surprisingly, almost half of the transcribed RNA represents non-
coding RNAs, raising a question about the functional roles of
these noncoding RNAs. The polycistronic transcript UL144-
145 RNA encodes the UL144 and UL145 ORFs and a 240 nt
intergenic noncoding sequence. Thus, UL144-145 RNA exhibits
features of both coding and noncoding RNA. The UL144 ORF
encodes a homolog of the tumor necrosis factor receptor
(TNFR) superfamily and facilitates HCMV immune surveillance
evasion (Poole et al., 2006). The UL145 ORF encodes a polypep-
tide (Stern-Ginossar et al., 2012) with an as-yet-unknown func-
tion (Wang et al., 2011).
In this study, we identified the 50-mer-core sequence within
intergenic RNA as a miRNA decay element (miRDE). The miRDE
alone was sufficient to mediate the degradation of the miR-17
family within the miR-17-92 cluster. Furthermore, the miRDE
could be retargeted to other miRNAs when the binding site for
the miRNA of interest was appropriately replaced. Based on
these observations and the predicted secondary structure of
the 240 nt intergenic RNA sequences containing miRDE (Fig-
ure 3E), we propose that the function of miRDE is likely to require
the unpaired structure of miRNA-binding site. The 30 additional
motif of miRDE was necessary for the efficient downregulation
of miR-17 family. This additional 30 motif might be involved in(D) Rescue experiment using an antisense oligomer against miR-17 and miR-
transfected to the infected HFFs. The cell-free virus in the supernatant was harves
antisense miR-17; A/S miR-20a, antisense miR-20a. The error bars represent ±
(E) Sequence comparison of miRDE in the UL144-145 intergenic region of HCMV
shown. The sequence of the miRNA decay element (miRDE) is boxed, and within
been noted. See also Figure S6.
Cell Hthe recruitment of trans-factors, such as ribonuclease and
RNA binding proteins. Alternatively, this motif might provide a
rigid structural framework required for miRDE function. This
virus-derived miRDE might be useful as a research tool and in
therapeutics. Evidence, albeit limited, suggests that viruses
use their own RNA to regulate host miRNAs. The noncoding
RNA HSUR1 of Herpesvirus saimiri (Cazalla et al., 2010) and
the 1.7 kb m169 transcript of murine cytomegalovirus (Libri
et al., 2012; Marcinowski et al., 2012) mediate the degradation
of thematuremiR-27. Based on these studies and the results ob-
tained here, we speculate that the cellular noncoding RNA
genome also plays a role in regulating the turnover of mature
miRNAs.
Why would HCMV have evolved a miR-17 degradation
mechanism during lytic infection? In the present study, the
downregulation of miR-17 accelerated viral production during
lytic infection in fibroblasts. During lytic infection, the mutant
virus, ToledoD17Seed, delayed viral production (after approxi-
mately 1 day) and genome synthesis. Accelerated viral growth
could provide a fitness advantage. Previous studies on RNA
viruses have shown that small increases in the rate of replication
are sufficient to exclude other competitor strains, even when the
increases are marginal (Nowak and May, 2000). A recent study
has provided evidence that HCMV gains a fitness advantage
by accelerating IE2 expression, without amplifying the final
expression levels, and that rapid viral lytic cycles resulting from
accelerated IE2 expression play a role in outcompeting nonac-
celerated virus, leading to dominant growth (Teng et al., 2012).
These studies indicate that the accelerated growth of HCMV
by miR-17 downregulation might contribute to virus fitness dur-
ing lytic infection. Considering the remarkably broad cell tropism
of HCMV in vivo (Sinzger et al., 2008) and the host innate-
defense or inflammatory response, the accelerated viral produc-
tion could be advantageous during in vivo clinical infection. The
miR-17 family targets apoptotic and cell-cycle related genes
(Olive et al., 2010). Toledo-WT and ToledoD17Seed induced
similar and low levels of apoptosis during infection (Figure S6).
This observation is not surprising, because HCMV encodes
several antiapoptotic viral genes, such as UL37x1, UL36,
UL38, IE1, and IE2 (McCormick, 2008). These redundant viral
antiapoptotic genes could potentially regulate apoptosis during
Toledo-WT or ToledoD17Seed infection. Thus, the enhanced
growth of the clinical isolate Toledo-WT is not solely due to
blocking the antiapoptotic function of miR-17.
Given that the cell-cycle regulators in S phase, such as E2F1,
E2F2, and p21, are also targets of miR-17 (Olive et al., 2010), the
delayed viral growth of ToledoD17Seed might be associated
with cell-cycle arrest, consistent with the observation that the
delayed viral growth correlated with the reduced synthesis of
viral DNA genome (Figure 6). The physiological functions of
the increased levels of miRNAs of miR-17-92 (miR-18a, miR-
19a/b, and miR-92a) have not been explored. Because IE1 and20a during Toledo infection. At 1 dpi, 100 nM of antisense oligomers were
ted at the indicated times for titration. A/S Con, antisense Control; A/S miR-17,
1 SD.
clinical isolates. The conserved (red) and nonconserved sequences (blue) are
the box the sequences of the miR-17 binding site and 30 additional motif have
ost & Microbe 13, 678–690, June 12, 2013 ª2013 Elsevier Inc. 687
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19 and miR-92 target the apoptotic genes Pten and Bim (Olive
et al., 2010), we expect that the antiapoptotic function of IE1
and IE2 might be associated with miR-17-92 cluster induction.
One of the important features of miRNA is its clustering pro-
pensity. One-third of human miRNAs are likely encoded within
polycistronic miRNA clusters (Altuvia et al., 2005). Most studies
on clustered miRNAs focus on elucidating the coordinated func-
tion and expression of miRNAs in a cluster. Previous studies on
the oncogenic properties of miR-17-92 have shown that the
component miRNAs of miR-17-92 cooperate to induce tumori-
genesis (Mendell, 2008). In the present study, we observed
that HCMV differentially regulates the expression of the host
miRNA cluster, miR-17-92, through the manipulation of multiple
steps inmiRNA expression, suggesting that a singlemiRNA clus-
ter could generate multiple miRNA compositions upon receiving
a specific stimulus. miR-17-92 is a well-characterized oncogenic
miRNA. The sequences of the six mature miRNAs are highly
conserved in all vertebrates, and thesemiRNAs play critical roles
in the development of organs and cancer (Olive et al., 2010).
However, the molecular mechanisms underlying the pleiotropic
effects of these molecules remain unclear. These results provide
insights into the differential regulation of miRNA clusters and will
be helpful in future studies for determining the roles of these
miRNAs in human disease.EXPERIMENTAL PROCEDURES
Cells and Viruses
Human embryonic kidney 293T (HEK293T) cells were maintained in DMEM
medium (HyClone) containing 7.5% fetal bovine serum (FBS) (HyClone),
2 mM L-glutamine, 50 U/mL of penicillin, and 50 mg/mL of streptomycin.
HFFs (ATCC, passages 10–15) were grown in DMEM supplemented with
10% FBS. Bacterial artificial chromosomes (BACs) of Toledo, ToledoD15kb,
and AD169 were introduced into HFFs using electroporation (Gene-Pulser II,
Bio-Rad). After 2 weeks, the culture supernatants were collected and titrated
as infectious units after measuring the IE1-positive cells via immunofluores-
cence assays. Anti-IE1 (MAB810R, Millipore) and anti-gB (1-M-12, Santa
Cruz Biotechnology) antibodies were used for the immunoblotting analyses.
Adenoviruses expressing HCMV IE-1 (Ad-IE1) and IE2 (Ad-IE2) were provided
from Jin-Hyun Ahn. Actinomycin D (A9415) and CHX (C4859) were purchased
from Sigma.
miRNA Microarray
miRNA microarray experiments were performed to determine cellular miRNA
expression during HCMV infection. Total RNAs from the uninfected control,
Toledo-WT, and ToledoD15kb-infected HFFs were isolated using TRIzol re-
agent (Invitrogen). Each sample was prepared according to the Agilent miRNA
Microarray System protocol. The microarray data were deposited in NCBI-
GEO under accession number GSE43761.
Firefly Reporter Construction and Dual Luciferase Assay
We used pGL3-CMV (Promega), a firefly luciferase vector containing a CMV
promoter, to analyze the biological functions of UL144-145 RNA, and pRL-
TK (Promega), a Renilla luciferase vector, to serve as a control reporter. The
primers used in the reporter constructs are listed in Table S1. For miRNA tar-
geting assay, HEK293T cells (13 105 cells in 24-well plate) were cotransfected
with 1 ng of the firefly-240nt, 5 ng of Renilla luciferase vector, and 50 nM
miRNA by Lipofectamin (Invitrogen). Twenty-four hours later, firefly luciferase
activity was normalized to Renilla luciferase activity. The firefly and Renilla
luciferase activities were determined according to manufacturer’s instructions
(Dual-Luciferase Reporter Assay System, Promega) using a luminometer
(Berthold Technologies).688 Cell Host & Microbe 13, 678–690, June 12, 2013 ª2013 ElsevierNorthern Blot and qRT-PCR
The miRNA sequences in this study were obtained from miRBase (Sanger
Institute). The probes used for blotting miRNA were designed according to
the sequence database. Total RNAs from HFFs and HEK293T cells were iso-
lated using TRIzol reagent (Invitrogen). The total RNA was resolved on a gel
containing 15% acrylamide and 8 M urea, transferred onto a nylon membrane
(Zeta-probe GT, Bio-Rad), and EDC crosslinked for 1 hr (Pall and Hamilton,
2008). Hybridization was performed in a hybridization solution (Clontech) for
3 hr at 37C, and the FUJI BAS filmwas exposed for 1 day. Total RNAwas sub-
sequently reverse transcribed with oligo-dT using M-MLV reverse transcrip-
tase (Invitrogen) for 1 hr at 37C and PCR amplified using the iQ SYBR Green
Supermix (Bio-Rad). The expression levels for the pri-miRNAs and target
mRNAs were normalized to GAPDH mRNA expression levels. The cellular
miRNAs were quantified through qRT-PCR using the miRNA assay kit
(Taqman). Mature miRNAs were normalized to U6 snRNA. The experimental
procedures were performed according to manufacturers’ instructions.
Transfection of Small RNA and Plasmid DNA
Small RNAs (i.e., RNA oligomers, siRNAs, and miRNA inhibitors) were trans-
fected using the Dharmafect 1 reagent (Dharmacon). Twenty-four hours prior
to transfection, HFFs and HEK293T cells were seeded onto a 12-well culture
plate in the appropriate complete growth medium without antibiotics. The
small RNAs and Dharmafect mixture were added into the culture medium,
and a final concentration of approximately 50 nM was achieved. The transfec-
tion mixture was replaced with fresh medium after 6 hr, and the transfected
cells were used for analysis at 48 hr posttransfection. We used the following
siRNAs: IE1, GCGGGAGAUGUGGAUGGCUdTdT; IE2, AAACGCAUCUCCG
AGUUGGACdTdT; Ago1, GAGAAGAGGUGCUCAAGAAUU; Ago2, GCACGG
AAGUCCAUCUGAAUU; Ago3, GAAAUUAGCAGAUUGGUAAUU; and Ago4,
GGCCAGAACUAAUAGCAAUUU. In addition, the following synthetic miR-17
duplexes were used: miR-17, pCAAAGUGCUUACAGUGCAGGUAG; and
miR-17*, pACUGCAGUGAAGGCACUUGUAG. The sequences of the miRDE
series are presented in Figure S3. The synthetic RNAs were purchased from
IDT. Antisense inhibitors of miRNAs were chemically synthesized by Dharma-
con. The synthetic miRNA inhibitors (miRIDIAN) for human miR-17 and miR-
20a were used in our experiments in combination.
HEK293T cells were transfected with DNA plasmids using the calcium phos-
phate method. HFFs were electroporated using Neon (Invitrogen) under pre-
optimized conditions.
Statistical Analysis
Unless otherwise noted, statistical significance was analyzed by the Student’s
t test and data represent the mean ± SD. All data in this study were obtained at
least in three independent experiments.
ACCESSION NUMBERS
The Gene Expression Omnibus (GEO) accession number for the microarray
data is GSE43761.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
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